FDA Approved: BRIVIACT — Supplemental Application (UCB, Inc.)

View source ↗

Summary

FDA approved a supplemental application for BRIVIACT (brivaracetam) filed by UCB, Inc. The approval confirms modifications to the drug's labeling as part of the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Partial-onset Seizures

Drugs mentioned

• Briviact (brivaracetam)

Snippet

SUPPL AP for BRIVIACT (BRIVARACETAM)